A Prat Selected Research

A Prat Research Topics

Disease

14	Breast Neoplasms (Breast Cancer) 03/2021 - 08/2012
14	Neoplasms (Cancer) 01/2021 - 08/2001
4	Multiple Sclerosis 01/2022 - 02/2000
4	Pathologic Complete Response 08/2019 - 01/2018
2	Chronic Progressive Multiple Sclerosis 01/2019 - 02/2000
2	Triple Negative Breast Neoplasms 02/2015 - 10/2014
2	Human Influenza (Influenza) 05/2009 - 11/2006
2	Autoimmune Diseases (Autoimmune Disease) 02/2008 - 02/2000
1	Relapsing-Remitting Multiple Sclerosis 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2019
1	Melanoma (Melanoma, Malignant) 01/2017
1	Aneurysm (Aneurysms) 04/2015
1	Inflammation (Inflammations) 02/2015
1	Neoplasm Metastasis (Metastasis) 02/2015
1	Circulating Neoplastic Cells 02/2015
1	Carcinogenesis 02/2015
1	Hemorrhage 11/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2011
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2011
1	Obesity 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Urinary Incontinence 01/2011
1	Fibrosis (Cirrhosis) 02/2010
1	Neuroinflammatory Diseases 02/2008
1	Residual Neoplasm 02/2008
1	Arthritis (Polyarthritis) 02/2008
1	Acute Lung Injury 12/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2007
1	Air Embolism (Gas Embolism) 05/2007
1	Hepatitis B 03/2005
1	Pneumonia (Pneumonitis) 03/2005
1	Hepatitis A (Hepatitis, Infectious) 03/2005
1	Otitis Media 03/2005
1	Hepatitis 03/2005
1	Hematoma 02/2004
1	Carcinoma (Carcinomatosis) 08/2001

Drug/Important Bio-Agent (IBA)

3	Phenobarbital (Luminal)FDA Link 08/2019 - 11/2012
2	Lapatinib (GW572016)FDA Link 01/2019 - 10/2016
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 10/2016
2	ClaudinsIBA 02/2015 - 04/2014
2	CytokinesIBA 02/2015 - 08/2000
2	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2009 - 11/2006
2	VaccinesIBA 05/2009 - 03/2005
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022
1	Natalizumab (Tysabri)FDA Link 01/2022
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	IntegrinsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Glial Cell Line-Derived Neurotrophic Factor ReceptorsIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	ocrelizumabIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	human ERBB2 proteinIBA 01/2019
1	ParaffinIBA 10/2018
1	Messenger RNA (mRNA)IBA 10/2018
1	Formaldehyde (Formol)FDA Link 10/2018
1	AntibodiesIBA 02/2015
1	Interleukin-6 (Interleukin 6)IBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2014
1	Pharmaceutical PreparationsIBA 03/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2014
1	tyrosine receptor (receptor, tyrosine)IBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	Tamoxifen FDA LinkGeneric 11/2012
1	Aurora Kinase AIBA 08/2012
1	Connective Tissue Growth FactorIBA 02/2010
1	Inflexal VIBA 05/2009
1	KininsIBA 02/2008
1	Carboplatin (JM8)FDA LinkGeneric 02/2008
1	taxaneIBA 02/2008
1	Docetaxel (Taxotere)FDA Link 12/2007
1	Bevacizumab (Avastin)FDA Link 12/2007
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 03/2005
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 03/2005
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2001
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 08/2001

Therapy/Procedure

10	Therapeutics 01/2019 - 08/2000
6	Drug Therapy (Chemotherapy) 01/2019 - 10/2014
4	Neoadjuvant Therapy 03/2021 - 04/2014
2	Immunotherapy 01/2021 - 01/2017
2	Stents 05/2007 - 08/2000
1	Deep Hypothermia Induced Circulatory Arrest 04/2015
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 04/2015
1	Sternotomy 11/2012
1	Splenectomy 01/2011
1	Combination Drug Therapy (Combination Chemotherapy) 02/2008
1	Adjuvant Chemotherapy 07/2007
1	Middle Ear Ventilation (Tympanostomy) 03/2005
1	Punctures 02/2004